1. From the Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, and the Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland; and the Institute of Molecular Medicine, Nuffield Department of Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, United Kingdom